Biogen’s Spinraza scores later-onset SMA data for stepped-up push with payers esagonowsky Mon, 04/24/2017 – 14:36 More: Biogen's Spinraza scores later-onset SMA data for stepped-up push with payers Source: fierce
read moreEMA spanks Brazilian manufacturer as sterile plant falls short epalmer Mon, 04/24/2017 – 14:27 More: EMA spanks Brazilian manufacturer as sterile plant falls short Source: fierce
read moreSun Pharma’s FDA quagmire gets stickier with citation of Dadra plant epalmer Mon, 04/24/2017 – 12:10 More: Sun Pharma's FDA quagmire gets stickier with citation of Dadra plant Source: fierce
read moreBrace yourself, pharma: Your beloved tax inversions could make a comeback chelfand Mon, 04/24/2017 – 11:27 More: Brace yourself, pharma: Your beloved tax inversions could make a comeback Source: fierce
read moreSamsung biosim nod sets J&J’s Remicade up for tough fight with Merck and Pfizer tracy Mon, 04/24/2017 – 10:52 More: Samsung biosim nod sets J&J's Remicade up for tough fight with Merck and Pfizer Source: fierce
read moreEleven new medicines have taken a giant leap towards approval in Europe after winning backing from the European Medicines Agency’s Committee for Medicinal Product for Human Use (CHMP), including two that treat rare neurodegenerative conditions in children. More: CHMP backs
read more© 1994 - 2026 B.M. Pharmaceuticals